l#
Table of Contents
e e l#
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines l#.................................................
e e e e e e e e
l# 3 l#Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics
e e e e
l# ...................................................................... l#13 l#
Chapter4: Pharmacogenetics and Pharmacogenomics l#.................................................................................
e e e
l#25 l#
Chapter 5: Pharmacology Across the Life Span l#...........................................................................................
e e e e e e
l#30 l#
, Chapter 6: Drug-Therapy Prescribing in Special Populations l#.......................................................................
e e e e e e
l#36 l#
Chapter 7: Drug Development and Approval l#...............................................................................................
e e e e e
l#45 l#
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
e e e e e e e e e
Substance Prescribing Chapter 10: Antibiotic Stewardship l#..........................................................................
e e e e e
l#51 l#
Chapter 11: Applied Calculations for Prescribing l#........................................................................................
e e e e e
l#58 l#
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
e e e e e e e e e
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14:
e e e e e e e e e e e e
Pharmacotherapy for Eye Conditions l#..........................................................................................................
e e e e
l# 67 l#Chapter 15: Pharmacotherapy for Skin Conditions
e e e e e
l# ...................................................................................... l#74 l#
Chapter 16: Pharmacotherapy for Neurologic Conditions l#............................................................................
e e e e e
l#81 l#
Chapter 17: Pharmacotherapy for Cardiovascular Conditions l#.....................................................................
e e e e e
l#94 l#
Chapter 18: Pharmacotherapy for Respiratory Conditions l#.........................................................................
e e e e e
l#106 l#
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Support
e e e e e e e e e
l#...................................................................................................................................................................
l#117 l#
Chapter 20: Pharmacotherapy for Genitourinary Conditions l#.....................................................................
e e e e e
l#128 l#
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders l#.............................
e e e e e e e e e
l# 133 l#Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions
e e e e e e e
l# .................................. l#146 l#
Chapter 23: Therapeutic Applications of Immunology and Vaccines l#........................................................
e e e e e e e
l#158 l#
Chapter 24: Pharmacotherapy for Endocrine Disorders l#.............................................................................
e e e e e
l#163 l#
Chapter 25: Pharmacotherapy for Hematologic Disorders l#.........................................................................
e e e e e
l#174 l#
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist l#.......................................
e e e e e e e e
l#190 l#
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions l#..................................................... l#196
e e e e e e e
l# Chapter 28: Pharmacotherapy Related to Men’s Health Conditions l#........................................................... l#211
e e e e e e e
l#
Chapter 29: Pharmacotherapy Related to Transgender Care l#......................................................................
e e e e e e
l#217 l#
Chapter 30: Antimicrobial Pharmacotherapy l#.............................................................................................
e e e
l#224 l#
Chapter 31: Antiretroviral Pharmacotherapy l#..............................................................................................
e e e
l#235 l#
, Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neurocog
e e e e e e e e e e
nitive Conditions l#........................................................................................................................................ l#247
e
l# Chapter 33: Pharmacotherapy for Pain Management l#................................................................................. l#257
e e e e e
l# Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance l#............................................ l#267
e e e e e e e e e
l#
Chapter 35: Over-the-Counter Medications l#...............................................................................................
e e e
l#283 l#
Chapter 36: Pharmacotherapy for Obesity l#.................................................................................................
e e e e
l#291 l#
l#
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines l#
e e e e e e e e
MULTIPLE CHOICE l# e
l#
• l# What is the primary purpose of the nursing assessment? l#
e e e e e e e e
l#
A. Identifying underlying pathologic conditions l# e e e
B. Assisting the physician in identifying medical conditions l# e e e e e e
C. Determining the patients mental status l# e e e e
D. Exploring patient responses to health problems l# e e e e e
l#
ANS: D l# e
l#
A nursing assessment is done to identify the patients response to health probl
e e e e e e e e e e e e
l#ems. During the nursing assessment phase, a comprehensive information ba
e e e e e e e e e
s
l#e is developed through a physical examination, nursing history, medication h
e e e e e e e e e e
i
l#story, and professional observation. Identifying underlying pathologic condi
e e e e e e e
t
l#ions and assisting the physician in identifying medical conditions is not part
e e e e e e e e e e e e
o l#f the nursing process. Determining the patients mental status l#is one part
e e e e e e e e e e e e
l#of th l#e l#nursing assessment, but l#it is l#not the primary purpose. l#
e e e e e e e e e e
DIF: Cognitive Level: Comprehension
e e e e
l#REF: dm 36 OBJ: 1 | 3 TOP: Nursing Pr
e e e e e e e e e
l#ocess Step: Assessment l# e e
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance l#
e e e e e e e e
l#
• What is the basis of the NANDA I taxonomy? l#
e e e e e e e e
l#
A. Functional health patterns l# e e
B. Human response patterns l# e e
C. Basic human needs l# e e
D. Pathophysiologic needs l# e
l#
ANS: B l# e
l#
The l#NANDA l#I l#taxonomy l#identifies l#human l#response l#patterns. Functional
e e e e e e e e
l# components of health patterns are limited to activity, fluid volume, nutrition
e e e e e e e e e e e
l#, self care, and sensory perception. Basic human needs comprise less than m
e e e e e e e e e e e e
, l#erely health patterns. l#Pathophysiologic needs l#are not part of the scope of N
e e e e e e e e e e e e
l#ANDA I. l# e
DIF: Cognitive Level: Knowledge REF: l# pp. 37-
e e e e e e
38 OBJ: 5 TOP: l#Nursing Process Step: Diagnosis l#
e e e e e e
MSC: NCLEX Client Needs Category: Physiological Integrity l#
e e e e e e
• Which task is included in the assessment step of the nursing process? l#
e e e e e e e e e e e
l#
A. Establishing patient goals/outcomes l# e e
B. Implementing the nursing care plan (NCP) l# e e e e e
C. Measuring goal/outcome achievement l# e e
D. Collecting and communicating data l# e e e
l#
ANS: D l# e
l#
Data are collected and communicated in the assessment phase of the nursing
e e e e e e e e e e e e
l#process. Establishing goals is the function of planning. l#
e e e e e e e
Implementing the NCP is the function of implementation. Measuring outcom e e e e e e e e e
l#e achievement is the function of evaluation. l#
e e e e e e
l#
DIF: Cognitive Level: Comprehension
e e e e
l#REF: dm 36 OBJ: 2 | 3 TOP: Nursing Pr
e e e e e e e e e
l#ocess Step: Assessment l# e e
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance l#
e e e e e e e e
l#
• Which statement regarding nursing diagnoses is accurate? l#
e e e e e e
l#
a. Nursing diagnoses remain the same for as long as the disease is
e e e e e e e e e e e e
present. l#
b. Nursing diagnoses are written to identify disease states. l#
e e e e e e e
l#
c. Nursing diagnoses describe patient problems that nurses treat. l#
e e e e e e e
d. Nursing diagnoses identify causes related to illness. l# e e e e e e
l#
ANS: C l# e
l#
Diagnostic statements identify problems a nurse is independently able to trea
e e e e e e e e e e
l#t within the scope of professional practice. Nursing diagnoses vary with the c
e e e e e e e e e e e e
l#hanging condition of the patient. The response patterns are unique to the pati
e e e e e e e e e e e e
l#ent and are not disease specific. Nursing diagnoses describe the patients hum
e e e e e e e e e e e
l#an response pattern. l#
e e
l#
DIF: Cognitive Level: Comprehension l#
e e e
REF: pp. 37-38 OBJ: 5 TOP: Nursing l#
e e e e e e
Process Step: Diagnosis l# e e
MSC: NCLEX Client Needs Category: Physiological Integrity l#
e e e e e e
• What do the classification systems NIC and NOC provide? l#
e e e e e e e e
a. Individualized data banks of treatments related to disease processes e e e e e e e e
l#
Table of Contents
e e l#
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines l#.................................................
e e e e e e e e
l# 3 l#Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics
e e e e
l# ...................................................................... l#13 l#
Chapter4: Pharmacogenetics and Pharmacogenomics l#.................................................................................
e e e
l#25 l#
Chapter 5: Pharmacology Across the Life Span l#...........................................................................................
e e e e e e
l#30 l#
, Chapter 6: Drug-Therapy Prescribing in Special Populations l#.......................................................................
e e e e e e
l#36 l#
Chapter 7: Drug Development and Approval l#...............................................................................................
e e e e e
l#45 l#
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
e e e e e e e e e
Substance Prescribing Chapter 10: Antibiotic Stewardship l#..........................................................................
e e e e e
l#51 l#
Chapter 11: Applied Calculations for Prescribing l#........................................................................................
e e e e e
l#58 l#
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
e e e e e e e e e
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14:
e e e e e e e e e e e e
Pharmacotherapy for Eye Conditions l#..........................................................................................................
e e e e
l# 67 l#Chapter 15: Pharmacotherapy for Skin Conditions
e e e e e
l# ...................................................................................... l#74 l#
Chapter 16: Pharmacotherapy for Neurologic Conditions l#............................................................................
e e e e e
l#81 l#
Chapter 17: Pharmacotherapy for Cardiovascular Conditions l#.....................................................................
e e e e e
l#94 l#
Chapter 18: Pharmacotherapy for Respiratory Conditions l#.........................................................................
e e e e e
l#106 l#
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Support
e e e e e e e e e
l#...................................................................................................................................................................
l#117 l#
Chapter 20: Pharmacotherapy for Genitourinary Conditions l#.....................................................................
e e e e e
l#128 l#
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders l#.............................
e e e e e e e e e
l# 133 l#Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions
e e e e e e e
l# .................................. l#146 l#
Chapter 23: Therapeutic Applications of Immunology and Vaccines l#........................................................
e e e e e e e
l#158 l#
Chapter 24: Pharmacotherapy for Endocrine Disorders l#.............................................................................
e e e e e
l#163 l#
Chapter 25: Pharmacotherapy for Hematologic Disorders l#.........................................................................
e e e e e
l#174 l#
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist l#.......................................
e e e e e e e e
l#190 l#
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions l#..................................................... l#196
e e e e e e e
l# Chapter 28: Pharmacotherapy Related to Men’s Health Conditions l#........................................................... l#211
e e e e e e e
l#
Chapter 29: Pharmacotherapy Related to Transgender Care l#......................................................................
e e e e e e
l#217 l#
Chapter 30: Antimicrobial Pharmacotherapy l#.............................................................................................
e e e
l#224 l#
Chapter 31: Antiretroviral Pharmacotherapy l#..............................................................................................
e e e
l#235 l#
, Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neurocog
e e e e e e e e e e
nitive Conditions l#........................................................................................................................................ l#247
e
l# Chapter 33: Pharmacotherapy for Pain Management l#................................................................................. l#257
e e e e e
l# Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance l#............................................ l#267
e e e e e e e e e
l#
Chapter 35: Over-the-Counter Medications l#...............................................................................................
e e e
l#283 l#
Chapter 36: Pharmacotherapy for Obesity l#.................................................................................................
e e e e
l#291 l#
l#
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines l#
e e e e e e e e
MULTIPLE CHOICE l# e
l#
• l# What is the primary purpose of the nursing assessment? l#
e e e e e e e e
l#
A. Identifying underlying pathologic conditions l# e e e
B. Assisting the physician in identifying medical conditions l# e e e e e e
C. Determining the patients mental status l# e e e e
D. Exploring patient responses to health problems l# e e e e e
l#
ANS: D l# e
l#
A nursing assessment is done to identify the patients response to health probl
e e e e e e e e e e e e
l#ems. During the nursing assessment phase, a comprehensive information ba
e e e e e e e e e
s
l#e is developed through a physical examination, nursing history, medication h
e e e e e e e e e e
i
l#story, and professional observation. Identifying underlying pathologic condi
e e e e e e e
t
l#ions and assisting the physician in identifying medical conditions is not part
e e e e e e e e e e e e
o l#f the nursing process. Determining the patients mental status l#is one part
e e e e e e e e e e e e
l#of th l#e l#nursing assessment, but l#it is l#not the primary purpose. l#
e e e e e e e e e e
DIF: Cognitive Level: Comprehension
e e e e
l#REF: dm 36 OBJ: 1 | 3 TOP: Nursing Pr
e e e e e e e e e
l#ocess Step: Assessment l# e e
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance l#
e e e e e e e e
l#
• What is the basis of the NANDA I taxonomy? l#
e e e e e e e e
l#
A. Functional health patterns l# e e
B. Human response patterns l# e e
C. Basic human needs l# e e
D. Pathophysiologic needs l# e
l#
ANS: B l# e
l#
The l#NANDA l#I l#taxonomy l#identifies l#human l#response l#patterns. Functional
e e e e e e e e
l# components of health patterns are limited to activity, fluid volume, nutrition
e e e e e e e e e e e
l#, self care, and sensory perception. Basic human needs comprise less than m
e e e e e e e e e e e e
, l#erely health patterns. l#Pathophysiologic needs l#are not part of the scope of N
e e e e e e e e e e e e
l#ANDA I. l# e
DIF: Cognitive Level: Knowledge REF: l# pp. 37-
e e e e e e
38 OBJ: 5 TOP: l#Nursing Process Step: Diagnosis l#
e e e e e e
MSC: NCLEX Client Needs Category: Physiological Integrity l#
e e e e e e
• Which task is included in the assessment step of the nursing process? l#
e e e e e e e e e e e
l#
A. Establishing patient goals/outcomes l# e e
B. Implementing the nursing care plan (NCP) l# e e e e e
C. Measuring goal/outcome achievement l# e e
D. Collecting and communicating data l# e e e
l#
ANS: D l# e
l#
Data are collected and communicated in the assessment phase of the nursing
e e e e e e e e e e e e
l#process. Establishing goals is the function of planning. l#
e e e e e e e
Implementing the NCP is the function of implementation. Measuring outcom e e e e e e e e e
l#e achievement is the function of evaluation. l#
e e e e e e
l#
DIF: Cognitive Level: Comprehension
e e e e
l#REF: dm 36 OBJ: 2 | 3 TOP: Nursing Pr
e e e e e e e e e
l#ocess Step: Assessment l# e e
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance l#
e e e e e e e e
l#
• Which statement regarding nursing diagnoses is accurate? l#
e e e e e e
l#
a. Nursing diagnoses remain the same for as long as the disease is
e e e e e e e e e e e e
present. l#
b. Nursing diagnoses are written to identify disease states. l#
e e e e e e e
l#
c. Nursing diagnoses describe patient problems that nurses treat. l#
e e e e e e e
d. Nursing diagnoses identify causes related to illness. l# e e e e e e
l#
ANS: C l# e
l#
Diagnostic statements identify problems a nurse is independently able to trea
e e e e e e e e e e
l#t within the scope of professional practice. Nursing diagnoses vary with the c
e e e e e e e e e e e e
l#hanging condition of the patient. The response patterns are unique to the pati
e e e e e e e e e e e e
l#ent and are not disease specific. Nursing diagnoses describe the patients hum
e e e e e e e e e e e
l#an response pattern. l#
e e
l#
DIF: Cognitive Level: Comprehension l#
e e e
REF: pp. 37-38 OBJ: 5 TOP: Nursing l#
e e e e e e
Process Step: Diagnosis l# e e
MSC: NCLEX Client Needs Category: Physiological Integrity l#
e e e e e e
• What do the classification systems NIC and NOC provide? l#
e e e e e e e e
a. Individualized data banks of treatments related to disease processes e e e e e e e e
l#
